9th Annual Biomarkers Congress
4th Cancer Targets and Therapeutics
Palms Casino Resort / Palms Place
4381 West Flamingo Road
Las Vegas, NV
http://www.gtcbio.com/component/conference/?file=home&cn=4th+Cancer+Targets+and+Therapeutics&cid=60
4th Cancer Targets and Therapeutics
Global Technology Community
Palms Casino Resort / Palms Place
Las Vegas
NV

Schedule of Presentations:

Monday, February 25, 2013
06:00:00 New Presentation
06:00:00 Targeting Inhibitor of Apoptosis (IAP) Proteins for Anti-cancer Therapies Domagoj Vucic
07:00:00 Registration & Continental Breakfast
07:55:00 Welcome & Opening Remarks
08:00:00 Intracellular Proteolysis and the Ubiquitin System: From the Backyard to the Center Stage of Biomedicne Aaron Ciechanover
08:55:00 The Potential of Antibody Drug Conjugates: Hype or Reason to Hope?
10:05:00 Morning Networking Break
10:30:00 Efforts to Identify Druggable Targets in Medulloblastoma and Glioblastoma Nagi Ayad
10:55:00 Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention Shidong Jia
11:20:00 The JAX Patient Derived Xenograft Resource for Clinical Advancement
11:45:00 Preclinical Evaluation of the Mitotic Kinesin CENP-E Protein as a Therapeutic Target for Triple Negative Breast Cancers Pei-Pei Kung
12:10:00 Lunch on Your Own
13:30:00 The Resurgence of Covalent Drugs Juswinder Singh
13:55:00 Epigenetics: The Breaking Frontier of Drug Discovery
14:20:00 New Protein Arginine Methyltransferase Inhibitors as Cancer Therapeutics Yujun George Zheng
14:45:00 Regulation of Cancer Growth by Metabolites in Pentose Phosphate Pathway
15:10:00 Afternoon Networking Break
15:40:00 4SC-202: A Novel Epigenetic Modulator to Target Cancer Stem Cells Hella Kohlhof
16:05:00 Strong and Specific LSD1 Inhibitors for the Treatment of Cancer Tamara Maes
17:20:00 Oral Presentations from Exemplary Submitted Abstracts
17:50:00 Networking Reception and Poster Session
Tuesday, February 26, 2013
07:30:00 Continental Breakfast
08:00:00 Development of Highly Active Chimeric Antigen Receptors (CARs) for B-Cell Malignancies: CD19 and CD22
08:25:00 Adoptive T-cell Therapy for Melanoma: The Road to Commercialization Laszlo Radvanyi
08:50:00 Immunomodulation of NK Cells Through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma Synergy Holbrook Kohrt
09:15:00 Therapy-induced Immunogenic Modulation of Tumor Cells Enhances Killing by Cytotoxic T Lymphocytes and is Distinct From Immunogenic Cell Death James Hodge
10:05:00 Morning Networking Break
10:30:00 Development of Next Generation Angiogenesis Inhibitors Targeting Pathways Other than VEGF Charles P. Theuer
10:55:00 Using FDHT-PET and Preclinical Projections to Optimize Dose Selection of ARN=509 in mCRPC
12:35:00 Lunch Provided by GTC
14:00:00 Conference Concludes
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.